EUVIMEDEUVIMED entdecken
Crossref

Moderately Hypofractionated Online Adaptive Definitive Chemoradiotherapy for Cervical Cancer: Updated 2-Year Outcomes from a Prospective Institutional Study

Z. Zeng, J. Yan, K. Hu, F. Zhang

International Journal of Radiation Oncology*Biology*Physics · 2026-09 · 126 (1) · S152

DOI: 10.1016/j.ijrobp.2026.06.237 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Radiation Oncology*Biology*Physics, 2026-09. Verfasst von Z. Zeng und 3 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Zeng, Z., Yan, J., Hu, K., & Zhang, F. (2026). Moderately Hypofractionated Online Adaptive Definitive Chemoradiotherapy for Cervical Cancer: Updated 2-Year Outcomes from a Prospective Institutional Study. International Journal of Radiation Oncology*Biology*Physics, 126(1), S152. https://doi.org/10.1016/j.ijrobp.2026.06.237

Vancouver

Zeng Z, Yan J, Hu K, Zhang F. Moderately Hypofractionated Online Adaptive Definitive Chemoradiotherapy for Cervical Cancer: Updated 2-Year Outcomes from a Prospective Institutional Study. International Journal of Radiation Oncology*Biology*Physics. 2026;126(1):S152. doi:10.1016/j.ijrobp.2026.06.237

BibTeX
@article{Zeng2026,
  author = {Zeng, Z. and Yan, J. and Hu, K. and Zhang, F.},
  title = {Moderately Hypofractionated Online Adaptive Definitive Chemoradiotherapy for Cervical Cancer: Updated 2-Year Outcomes from a Prospective Institutional Study},
  journal = {International Journal of Radiation Oncology*Biology*Physics},
  year = {2026},
  volume = {126},
  number = {1},
  pages = {S152},
  doi = {10.1016/j.ijrobp.2026.06.237}
}
Kostenlos starten →